Bipolar depression

The real challenge

Robert M A Hirschfeld

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

This paper seeks to raise awareness of the impact and burden of bipolar depression and the need to improve its recognition and management in clinical practice. Bipolar depression is commonly misdiagnosed as unipolar depression and consequently, patients may receive inappropriate treatment that could potentially worsen symptoms. The Mood Disorder Questionnaire (MDQ) is a useful screening tool for identifying the range of bipolar spectrum disorders in general and psychiatric populations. Bipolar depression has a significant impact on patients, affecting work, social activities, family and friends. Current treatments for bipolar disorder have focused on mania, yet symptoms of bipolar depression occur more frequently, last longer, are more disruptive and are associated with greater risk of suicide than mania. In comparison with unipolar depression, bipolar depression is more severe, is associated with more frequent hospital visits and causes greater psychosocial impairment. These facts emphasise the importance of improving the diagnosis and treatment of bipolar depression.

Original languageEnglish (US)
JournalEuropean Neuropsychopharmacology
Volume14
Issue numberSUPPL. 2
DOIs
StatePublished - May 2004

Fingerprint

Bipolar Disorder
Depressive Disorder
Diagnostic Errors
Mood Disorders
Suicide
Psychiatry
Therapeutics

Keywords

  • Bipolar disorder
  • Depression
  • Diagnosis
  • Mania
  • Mood disorder questionnaire

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Neurology
  • Pharmacology
  • Psychology(all)

Cite this

Bipolar depression : The real challenge. / Hirschfeld, Robert M A.

In: European Neuropsychopharmacology, Vol. 14, No. SUPPL. 2, 05.2004.

Research output: Contribution to journalArticle

Hirschfeld, Robert M A. / Bipolar depression : The real challenge. In: European Neuropsychopharmacology. 2004 ; Vol. 14, No. SUPPL. 2.
@article{c6360e4510ab4b31a8f77ba5bb0f6f97,
title = "Bipolar depression: The real challenge",
abstract = "This paper seeks to raise awareness of the impact and burden of bipolar depression and the need to improve its recognition and management in clinical practice. Bipolar depression is commonly misdiagnosed as unipolar depression and consequently, patients may receive inappropriate treatment that could potentially worsen symptoms. The Mood Disorder Questionnaire (MDQ) is a useful screening tool for identifying the range of bipolar spectrum disorders in general and psychiatric populations. Bipolar depression has a significant impact on patients, affecting work, social activities, family and friends. Current treatments for bipolar disorder have focused on mania, yet symptoms of bipolar depression occur more frequently, last longer, are more disruptive and are associated with greater risk of suicide than mania. In comparison with unipolar depression, bipolar depression is more severe, is associated with more frequent hospital visits and causes greater psychosocial impairment. These facts emphasise the importance of improving the diagnosis and treatment of bipolar depression.",
keywords = "Bipolar disorder, Depression, Diagnosis, Mania, Mood disorder questionnaire",
author = "Hirschfeld, {Robert M A}",
year = "2004",
month = "5",
doi = "10.1016/j.euroneuro.2004.03.001",
language = "English (US)",
volume = "14",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Bipolar depression

T2 - The real challenge

AU - Hirschfeld, Robert M A

PY - 2004/5

Y1 - 2004/5

N2 - This paper seeks to raise awareness of the impact and burden of bipolar depression and the need to improve its recognition and management in clinical practice. Bipolar depression is commonly misdiagnosed as unipolar depression and consequently, patients may receive inappropriate treatment that could potentially worsen symptoms. The Mood Disorder Questionnaire (MDQ) is a useful screening tool for identifying the range of bipolar spectrum disorders in general and psychiatric populations. Bipolar depression has a significant impact on patients, affecting work, social activities, family and friends. Current treatments for bipolar disorder have focused on mania, yet symptoms of bipolar depression occur more frequently, last longer, are more disruptive and are associated with greater risk of suicide than mania. In comparison with unipolar depression, bipolar depression is more severe, is associated with more frequent hospital visits and causes greater psychosocial impairment. These facts emphasise the importance of improving the diagnosis and treatment of bipolar depression.

AB - This paper seeks to raise awareness of the impact and burden of bipolar depression and the need to improve its recognition and management in clinical practice. Bipolar depression is commonly misdiagnosed as unipolar depression and consequently, patients may receive inappropriate treatment that could potentially worsen symptoms. The Mood Disorder Questionnaire (MDQ) is a useful screening tool for identifying the range of bipolar spectrum disorders in general and psychiatric populations. Bipolar depression has a significant impact on patients, affecting work, social activities, family and friends. Current treatments for bipolar disorder have focused on mania, yet symptoms of bipolar depression occur more frequently, last longer, are more disruptive and are associated with greater risk of suicide than mania. In comparison with unipolar depression, bipolar depression is more severe, is associated with more frequent hospital visits and causes greater psychosocial impairment. These facts emphasise the importance of improving the diagnosis and treatment of bipolar depression.

KW - Bipolar disorder

KW - Depression

KW - Diagnosis

KW - Mania

KW - Mood disorder questionnaire

UR - http://www.scopus.com/inward/record.url?scp=2342548183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342548183&partnerID=8YFLogxK

U2 - 10.1016/j.euroneuro.2004.03.001

DO - 10.1016/j.euroneuro.2004.03.001

M3 - Article

VL - 14

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

IS - SUPPL. 2

ER -